Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Allakos Inc (NQ: ALLK ) 0.7151 +0.0105 (+1.49%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 121,070 Open 0.7000 Bid (Size) 0.7060 (45) Ask (Size) 0.7208 (17) Prev. Close 0.7046 Today's Range 0.7000 - 0.7397 52wk Range 0.6348 - 3.405 Shares Outstanding 86,560,315 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News ALLK Stock Earnings: Allakos Beats EPS for Q2 2024 August 07, 2024 ALLK stock results show that Allakos beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results August 07, 2024 From Allakos Inc. Via GlobeNewswire Performance YTD -73.90% -73.90% 1 Month -18.71% -18.71% 3 Month -49.64% -49.64% 6 Month -47.42% -47.42% 1 Year -75.84% -75.84% More News Read More Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile June 25, 2024 From Allakos Inc. Via GlobeNewswire Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria May 28, 2024 From Allakos Inc. Via GlobeNewswire ALLK Stock Earnings: Allakos Meets EPS for Q1 2024 May 09, 2024 Via InvestorPlace ALLK Stock Earnings: Allakos Misses EPS for Q4 2023 March 14, 2024 Via InvestorPlace Allakos Provides Business Update and Reports First Quarter 2024 Financial Results May 09, 2024 From Allakos Inc. Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday May 03, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's After-Market Session May 01, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday April 15, 2024 Via InvestorPlace 3 Biotech Stocks to Dump Before They Go to Zero April 09, 2024 Via InvestorPlace Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results March 14, 2024 From Allakos Inc. Via GlobeNewswire Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024 February 26, 2024 From Allakos Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session February 14, 2024 Via Benzinga Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition February 12, 2024 From Allakos Inc. Via GlobeNewswire Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday January 17, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session January 17, 2024 Via Benzinga Gold Down 1%; PNC Financial Posts Upbeat Earnings January 16, 2024 Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Tuesday's Intraday Session January 16, 2024 Via Benzinga Crude Oil Edges Lower; Morgan Stanley Posts Upbeat Revenue January 16, 2024 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Is Allakos (ALLK) Stock Down 57% Today? January 16, 2024 Via InvestorPlace Trial Setback: Allakos Drops Lead Skin Disorder Candidate, Cuts Workforce By 50% January 16, 2024 Via Benzinga Dow Dips 200 Points; Goldman Sachs Earnings Top Views January 16, 2024 Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Tuesday's Pre-Market Session January 16, 2024 Via Benzinga Allakos Announces a Restructuring to Focus on Development of AK006 January 16, 2024 From Allakos Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
